Safety and Efficacy of CTX001 in Patients with TransfusionDependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells
Keywords:
-Downloads
Download data is not yet available.
Downloads
Published
2021-06-17
Issue
Section
ย่อวารสาร (Journal Club)